(Q35840024)

10 August 2017

1 reference

title

Selection criteria for genetic assessment of patients with familial melanoma (English)

1 reference

Brigitte Bressac-de Paillerets

10 August 2017

1 reference

9

Brigitte Bressac-de Paillerets

0 references

Giovanna Bianchi-Scarrà

7

Giovanna Bianchi-Scarrà

1 reference

10 August 2017

Kimberly C Banks

4

0 references

William Bruno

William Bruno

10

0 references

Graham J Mann

Graham J Mann

23

0 references

Susana Puig

Susana Puig

28

0 references

Richard F. Kefford

Richard F Kefford

20

0 references

John Carucci

John Carucci

2

0 references

Håkan Olsson

Håkan Olsson

26

0 references

Julia A Newton Bishop

25

Julia Newton-Bishop

1 reference

10 August 2017

13

Tadeusz Debniak

1 reference

10 August 2017

27

Gloria M Petersen

1 reference

10 August 2017

Sancy A Leachman

1

1 reference

10 August 2017

Wendy Kohlmann

3

1 reference

10 August 2017

Maryam M Asgari

5

1 reference

10 August 2017

Wilma Bergman

6

1 reference

10 August 2017

Teresa Brentnall

8

1 reference

10 August 2017

Clara Curiel-Lewandrowski

11

1 reference

10 August 2017

Femke A de Snoo

12

1 reference

10 August 2017

Marie-France Demierre

14

1 reference

10 August 2017

David Elder

15

1 reference

10 August 2017

Alisa M Goldstein

16

1 reference

10 August 2017

Jane Grant-Kels

17

1 reference

10 August 2017

Allan C Halpern

18

1 reference

10 August 2017

Christian Ingvar

19

1 reference

10 August 2017

Julie Lang

21

1 reference

10 August 2017

Rona M MacKie

22

1 reference

10 August 2017

Kurt Mueller

24

1 reference

10 August 2017

Darrell Rigel

29

1 reference

10 August 2017

Susan M Swetter

30

1 reference

10 August 2017

Margaret A Tucker

31

1 reference

10 August 2017

Emanuel Yakobson

32

1 reference

10 August 2017

John A Zitelli

33

1 reference

10 August 2017

Hensin Tsao

34

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Journal of the American Academy of Dermatology

10 August 2017

1 reference

10 August 2017

61

1 reference

10 August 2017

4

1 reference

10 August 2017

677.e1-14

1 reference

High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Clinicopathological features of and risk factors for multiple primary melanomas

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Role of the CDKN2A locus in patients with multiple primary melanomas

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Pancreatic carcinoma surveillance in patients with familial melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Genetic testing for melanoma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Geographical variation in the penetrance of CDKN2A mutations for melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Multiple primary melanoma revisited

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Mutation testing in melanoma families: INK4A, CDK4 and INK4D

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Risk of Developing Cutaneous Malignant Melanoma in Atypical-Mole Syndrome: New York University Experience and Literature Review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Familial atypical multiple mole-melanoma syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Genetic susceptibility in familial melanoma from northeastern Italy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

INK4/ARF germline alterations in pancreatic cancer patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2A germline mutations in familial pancreatic cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Online.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Cutaneous phenotype andMC1R variants as modifying factors for the development of melanoma inCDKN2A G101W mutation carriers from 4 countries

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Heterogeneity of risk for melanoma and pancreatic and digestive malignancies

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Predicting the Risk of Pancreatic Cancer: OnCDKN2AMutations in the Melanoma-Pancreatic Cancer Syndrome in Italy

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

From sporadic atypical nevi to familial melanoma: Risk analysis for melanoma in sporadic atypical nevus patients

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

The Atypical-Mole Syndrome and Predisposition to Melanoma

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

14 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3307795

CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma

14 November 2018

1 reference

12 December 2020

Genetic and environmental influences in the development of multiple primary melanoma

1 reference

12 December 2020

CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas

1 reference

12 December 2020

American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma

1 reference

12 December 2020

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia

1 reference

12 December 2020

Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients

1 reference

12 December 2020

Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome

1 reference

12 December 2020

Population-Based Analysis of Prognostic Factors and Survival in Familial Melanoma

1 reference

12 December 2020

CDKN2A mutations in Scottish families with cutaneous melanoma: results from 32 newly identified families

1 reference

12 December 2020

Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain

1 reference

12 December 2020

Nevus Distribution in a Utah Melanoma Kindred with a Temperature-Sensitive CDKN2A Mutation

1 reference

12 December 2020

Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma

1 reference

12 December 2020

The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma

1 reference

12 December 2020

Population-Based Prevalence of CDKN2A Mutations in Utah Melanoma Families

1 reference

12 December 2020

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations

1 reference

12 December 2020

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations

1 reference

12 December 2020

Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations

1 reference

12 December 2020

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families

1 reference

12 December 2020

Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families

1 reference

12 December 2020

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden)

1 reference

12 December 2020

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma

1 reference

12 December 2020

Multiple primary tumors as an indicator for p16INK4a germline mutations in pancreatic cancer patients?

1 reference

12 December 2020

Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families

1 reference

12 December 2020

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas

1 reference

12 December 2020

High prevalence of the G101W germline mutation in theCDKN2A(P16ink4a) gene in 62 Italian malignant melanoma families

1 reference

12 December 2020

Analysis of the p16 gene status of non-familial dysplastic nevus syndrome patients

1 reference

12 December 2020

Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population

1 reference

12 December 2020

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers

1 reference

12 December 2020

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing

1 reference

12 December 2020

Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome

1 reference

12 December 2020

Familial melanoma, pancreatic cancer and germline CDKN2A mutations

1 reference

12 December 2020

Influence of Genes, Nevi, and Sun Sensitivity on Melanoma Risk in a Family Sample Unselected by Family History and in Melanoma-Prone Families

1 reference

12 December 2020

Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma

1 reference

12 December 2020

Atypical mole syndrome

1 reference

12 December 2020

Dysplastic nevi as a melanoma risk factor in patients with familial melanoma

1 reference

12 December 2020

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma

1 reference

12 December 2020

Germline CDKN2A mutations in childhood melanoma

1 reference

12 December 2020

Germline Mutations of the CDKN2 Gene in UK Melanoma Families

1 reference

12 December 2020

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]

1 reference

12 December 2020

CDKN2A mutations in multiple primary melanomas

1 reference

12 December 2020

CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families

1 reference

12 December 2020

Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland

1 reference

12 December 2020

10.1016/J.JAAD.2009.03.016

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

19751883

1 reference